Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Prostate cancer
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Histopathology == * Adenocarcinoma * Usually originates in PZ - so prostatectomy for BPH is not actually protective against developing cancer later * Incidence in men >80yo is about 70%, but most of these are tiny and may never cause a problem * Gleason score - two histological areas are scored between 1 and 5, giving an overall score of between 2 and 10. This appears to correlate well with the likelihood of spread. == Presentation == * Elevated PSA - about 30% of men with elevated PSA will have biopsy-confirmed prostate cancer * 20% of men with clinically significant prostate cancer will have normal PSA * T2 disease may present with a nodule on rectal examination, along with irregular induration, stony hard parts, and obliteration of the median sulcus == Natural history == * Only locally advanced tumours cause symptoms (T3 and T4), and these are not curable - about 50% progress to bony mets after 3-5 years * Curable tumours (T1 and T2) are found on screening or incidentally * It is not possible to know whether those early tumours were going to progress or not - about 10% progress over 8 years * Metastises to bone, but can also spread via lymphatics * Median survival of M1 disease about 3 years == Management: == * Low-risk: low PSA, small foci of Gleason 6 disease - surveillance generally, even if younger than 70 * Intermediate risk - radical prostatectomy or RTX in younger, fitter men * High risk (T3) - early androgen ablation +/- rtx +/- surgery for younger men * Advanced disease (T4 or any nodal or distant mets) is palliative * Radical prostatectomy ** Suitable for men with life expectancy >10 years ** Can give clear margins in T3a disease ** Need to exclude mets prior [[Category:Urology]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Prostate cancer
Add topic